---
title: Improve walking with transcranial stimulation
nct_id: NCT07291687
phase: NA
status: RECRUITING
sponsor: Baycrest
study_type: INTERVENTIONAL
canonical_url: "https://parkinsonspathways.com/trial/NCT07291687"
clinicaltrials_gov: "https://clinicaltrials.gov/study/NCT07291687"
last_fetched: "2026-05-10T14:06:23.916Z"
source: "Parkinson's Pathways (curated)"
---
# Improve walking with transcranial stimulation

**Goal (in five words):** Improve walking with transcranial stimulation

**Official Title:** Transcranial Direct Current Stimulation as a Treatment for Motor Function in Participants Living With Progressive Supranuclear Palsy, Corticalbasal Syndrome Degeneration, or Parkinson's Disease

**Trial ID:** [NCT07291687](https://clinicaltrials.gov/study/NCT07291687)

## Key Facts

- **Phase:** NA
- **Status:** RECRUITING
- **Study Type:** INTERVENTIONAL
- **Sponsor:** Baycrest
- **Target Enrollment:** 20 participants
- **Start Date:** 2025-10-30
- **Completion Date:** 2028-12
- **Conditions:** Progressive Supranuclear Palsy, Cortical Basal Ganglionic Degeneration, Parkinson Disease
- **Interventions:** Transcranial direct current stimulation (TDCS), Stimulation Arm
- **Intervention Types:** DEVICE

## Summary For Families

The trial is testing whether mild electrical brain stimulation can improve walking and other motor problems in people with progressive supranuclear palsy, corticobasal degeneration, or Parkinson's disease. It uses transcranial direct current stimulation, a low-intensity current applied to the scalp that changes cortical excitability to strengthen motor circuits; because it is a non-drug intervention it does not alter how levodopa is metabolized and can be given alongside usual Parkinson's meds. The study is looking for adults with one of those diagnoses who walk daily, either unaided or with a cane or walker, who can communicate in English, and who do not have metal implants in the brain such as shunts.

## Eligibility

- **Sex:** ALL

### Full Criteria

```
Inclusion Criteria:

\- 1. Participants must be able to walk unassisted, or with the assistance of a walker or cane, and be individuals who walk daily.

2\. Participants should have a sufficient level of English to be able to express themselves verbally, be able to read and follow instructions.

Exclusion Criteria:

* 3\. Individuals with metal implants within the brain such as shunts will be excluded.
```

## Locations (1)

- Baycrest Academy of Health Sciences and Geriatric Research, Toronto, Ontario, Canada _(43.7064, -79.3986)_

## Central Contacts

- Alice Zhang, B.Sc — (CONTACT) — (416) 785-2500 — azhang4@research.baycrest.org
- Tyler Roncero, Ph.D — (CONTACT) — T (416) 785-2500 — croncero@research.baycrest.org

---

*Canonical: https://parkinsonspathways.com/trial/NCT07291687*  
*HTML version: https://parkinsonspathways.com/trial/NCT07291687*  
*Source data: https://clinicaltrials.gov/study/NCT07291687*